Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Previous issues

Page Path
HOME > Browse articles > Previous issues
23 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 54(1); January 2021
Prev issue Next issue
Commentarys
Giant Rugae in Helicobacter pylori-Infected Stomachs
Sun-Young Lee
Clin Endosc 2021;54(1):1-3.   Published online January 21, 2021
DOI: https://doi.org/10.5946/ce.2021.007
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Preparation of 3D-printed gastric models with biomimetic mechanical, topographical and fluid dynamic properties
    Yu-Tung Hsu, Shiao-Pieng Lee, Chung-Hsing Li, Ming-Hua Ho, Chen-Yu Kao
    Journal of the Taiwan Institute of Chemical Engineers.2024; 160: 105389.     CrossRef
  • Type A, Type B, and Non-atrophic Gastritis
    Sun-Young Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 108.     CrossRef
  • Risk factors for early gastric cancer: focus on Helicobacter pylori gastritis
    Hee Seok Moon
    Journal of the Korean Medical Association.2022; 65(5): 259.     CrossRef
  • Serum Assay Findings after Successful Helicobacter pylori Eradication
    Sun-Young Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(4): 287.     CrossRef
  • 4,376 View
  • 178 Download
  • 2 Web of Science
  • 4 Crossref
Close layer
Colon Capsule Endoscopy: An Alternative for Conventional Colonoscopy?
Britt B.S.L. Houwen, Evelien Dekker
Clin Endosc 2021;54(1):4-6.   Published online January 21, 2021
DOI: https://doi.org/10.5946/ce.2021.047
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • TOP 100 and detection of colorectal lesions in colon capsule endoscopy: more than meets the eye
    Tiago Lima Capela, Cátia Arieira, Sofia Xavier, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Bruno Rosa, José Cotter
    European Journal of Gastroenterology & Hepatology.2024; 36(9): 1087.     CrossRef
  • Diagnostic Evaluation of Solid Pancreatic Lesions: Endoscopic Ultrasound-Guided Fine Needle Aspiration Versus Percutaneous Ultrasound-Guided Core Needle Biopsy
    Ismail Caymaz, Nargiz Afandiyeva
    CardioVascular and Interventional Radiology.2023; 46(11): 1596.     CrossRef
  • Examination of Entire Gastrointestinal Tract: A Perspective of Mouth to Anus (M2A) Capsule Endoscopy
    Ji Hyung Nam, Kwang Hoon Lee, Yun Jeong Lim
    Diagnostics.2021; 11(8): 1367.     CrossRef
  • 3,553 View
  • 119 Download
  • 2 Web of Science
  • 3 Crossref
Close layer
Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?
Ahmad Najdat Bazarbashi, Linda S. Lee
Clin Endosc 2021;54(1):7-8.   Published online January 25, 2021
DOI: https://doi.org/10.5946/ce.2021.046
PDFPubReaderePub
  • 2,880 View
  • 90 Download
Close layer
FOCUSED REVIEW SERIES: Endoscopic Managements for Patients with Obesity and Its Related Comorbiditieses
The Clinical and Metabolic Effects of Intragastric Balloon on Morbid Obesity and Its Related Comorbidities
Joon Hyun Cho, Mohammad Bilal, Min Cheol Kim, Jonah Cohen, The Study Group for Endoscopic Bariatric and Metabolic Therapies of the Korean Society of Gastrointestinal Endoscopy
Clin Endosc 2021;54(1):9-16.   Published online January 29, 2021
DOI: https://doi.org/10.5946/ce.2020.302
AbstractAbstract PDFPubReaderePub
Obesity is becoming increasingly prevalent worldwide, and its metabolic sequelae lead to a significant burden on healthcare resources. Options for the management of obesity include lifestyle modification, pharmacological treatment, surgery, and endoscopic bariatric therapies (EBTs). Among these, EBTs are more effective than diet and lifestyle modification and are less invasive than bariatric surgery. In recent years, there have been significant advances in technologies pertaining to EBTs. Of all the available EBTs, there is a significant amount of clinical experience and published data regarding intragastric balloons (IGBs) because of their comparatively long development period. Currently, the United States Food and Drug Administration (FDA) has approved three IGBs, including Orbera (Apollo Endosurgery, Austin, TX, USA), ReShape Duo (ReShape Medical, San Clemente, CA, USA), and Obalon (Obalon Therapeutics, Carlsbad, CA, USA). The aim of this review is to summarize the available literature on the efficacy of IGBs in weight loss and their impact on obesity-related metabolic diseases.

Citations

Citations to this article as recorded by  
  • Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control
    Willian Ferreira Igi, Victor Lira de Oliveira, Ayah Matar, Diogo Turiani Hourneaux de Moura
    Clinical Endoscopy.2024; 57(3): 309.     CrossRef
  • Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker
    Danut Dejeu, Paula Dejeu, Paula Bradea, Anita Muresan, Viorel Dejeu
    Clinics and Practice.2024; 14(3): 765.     CrossRef
  • Efficacy and safety of intragastric balloon for obesity in Korea
    Kwang Gyun Lee, Seung-Joo Nam, Hyuk Soon Choi, Hang Lak Lee, Jai Hoon Yoon, Chan Hyuk Park, Kyoung Oh Kim, Do Hoon Kim, Jung-Wook Kim, Won Sohn, Sung Hoon Jung
    Clinical Endoscopy.2023; 56(3): 333.     CrossRef
  • How effective is intragastric balloon insertion as an obesity treatment in Korea?
    Youngdae Kim
    Clinical Endoscopy.2023; 56(3): 310.     CrossRef
  • Overview on the endoscopic treatment for obesity: A review
    Maheeba Abdulla, Nafeesa Mohammed, Jehad AlQamish
    World Journal of Gastroenterology.2023; 29(40): 5526.     CrossRef
  • Endoscopic Bariatric Therapy for Obesity and Metabolic Syndrome
    Sang Pyo Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(4): 247.     CrossRef
  • Status of bariatric endoscopy–what does the surgeon need to know? A review
    Diogo Turiani Hourneaux de Moura, Anna Carolina Batista Dantas, Igor Braga Ribeiro, Thomas R McCarty, Flávio Roberto Takeda, Marco Aurelio Santo, Sergio Carlos Nahas, Eduardo Guimarães Hourneaux de Moura
    World Journal of Gastrointestinal Surgery.2022; 14(2): 185.     CrossRef
  • Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
    Hee Kyong Na, Diogo Turiani Hourneaux De Moura
    Clinical Endoscopy.2021; 54(1): 25.     CrossRef
  • 4,856 View
  • 206 Download
  • 7 Web of Science
  • 8 Crossref
Close layer
The Efficacy and Safety of Endoscopic Sleeve Gastroplasty as an Alternative to Laparoscopic Sleeve Gastrectomy
Jin Young Yoon, Román Turró Arau, The study group for endoscopic bariatric and metabolic therapies in the Korean Society of Gastrointestinal Endoscopy
Clin Endosc 2021;54(1):17-24.   Published online January 22, 2021
DOI: https://doi.org/10.5946/ce.2021.019
AbstractAbstract PDFPubReaderePub
Endoscopic sleeve gastroplasty (ESG) is a therapeutic endoscopic technique for reducing the size of the gastric reservoir in obese patients, using a full-thickness endoscopic suturing device. The effectiveness of ESG in weight loss is significantly greater than that of high-intensity diet and lifestyle therapy and lower than that of laparoscopic sleeve gastrectomy (LSG). The efficacy at 12 months after ESG in terms of percentage of total body weight loss and excess body weight loss was approximately 16% and 60%, respectively. The well-known predictive factors for increased weight loss by ESG are good compliance with regular monitoring and post-procedure care involving a multidisciplinary team approach. Although the underlying mechanism of weight loss induced by ESG is debatable, delayed gastric emptying and early satiation are some of the proposed mechanisms. The pooled rate of adverse events after ESG reported in several meta-analysis studies ranged from 1.5% to 2.3% and the incidence of new-onset gastroesophageal reflux disease after ESG was negligible, indicating that ESG has a superior safety profile to LSG. Moreover, ESG reduced the risk of obesity-related metabolic comorbidities, evidenced by the reduction in HbA1c level, systolic blood pressure, triglyceride level, and risk of hepatic steatosis and fibrosis; it even improved the quality of life. ESG could be considered safe and qualify as an alternative treatment to LSG.

Citations

Citations to this article as recorded by  
  • Performance of Endoscopic Sleeve Gastroplasty by Obesity Class in the United States Clinical Setting
    Khushboo Gala, Vitor Brunaldi, Christopher McGowan, Reem Z. Sharaiha, Daniel Maselli, Brandon Vanderwel, Prashant Kedia, Michael Ujiki, Eric Wilson, Eric J. Vargas, Andrew C. Storm, Barham K. Abu Dayyeh
    Clinical and Translational Gastroenterology.2024; 15(1): e00647.     CrossRef
  • Recent advances in therapeutic interventions of polycystic ovarian syndrome
    Sakshi Upendra Lad, Ganesh Sunil Vyas, Sharfuddin Mohd, Vijay Mishra, Sheetu Wadhwa, Saurabh Singh, Vancha Harish
    Obesity Medicine.2024; 48: 100543.     CrossRef
  • Fundus-to-Antrum Ratio Measured with Fluoroscopy within One Week after Endoscopic Sleeve Gastroplasty Predicts Total Body Weight Loss over Time
    Kaveh Hajifathalian, Kamal Amer, Dema Shamoon, Donevan Westerveld, Louis Aronne, Amit Mehta, Angela Wong, Grace Lo, Sarah Oh, Andrea Siobhan Kierans, Kamal M. Hassan, Ali Lahooti, Reem Z. Sharaiha
    Journal of Clinical Medicine.2024; 13(13): 3933.     CrossRef
  • Endoscopic treatment of obesity: A protocol of updated systematic review with network meta-analysis of randomized controlled trials
    Eun Jeong Gong, Chang Seok Bang, Gwang Ho Baik, Dong Keon Yon
    PLOS ONE.2024; 19(9): e0308410.     CrossRef
  • The Efficacy Comparison of Endoscopic Bariatric Therapies: 6-Month Versus 12-Month Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty
    K. Kozłowska-Petriczko, K. M. Pawlak, K. Wojciechowska, A. Reiter, Ł. Błaszczyk, J. Szełemej, J. Petriczko, A. Wiechowska-Kozłowska
    Obesity Surgery.2023; 33(2): 498.     CrossRef
  • Endobariatrics: a Still Underutilized Weight Loss Tool
    Niel Dave, Enad Dawod, Okeefe L. Simmons
    Current Treatment Options in Gastroenterology.2023; 21(2): 172.     CrossRef
  • Safety and efficacy of endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy in obese type 2 diabetes patients
    Vimal Thomas, Tarun Kumar Suvvari, Anu Varghese, Nikhat Kousar Ahmed, Yasmine Tarek Elsherif, Aasim Akthar Ahmed
    Surgery Open Digestive Advance.2023; 11: 100098.     CrossRef
  • Endoscopic Sleeve Gastroplasty: A Practice Pattern Survey
    James D. Haddad, Jaime P. Almandoz, Victoria Gomez, Allison R. Schulman, Jay D. Horton, Jeffrey Schellinger, Sarah E. Messiah, M. Sunil Mathew, Elisa Morales Marroquin, Anna Tavakkoli
    Obesity Surgery.2023; 33(8): 2434.     CrossRef
  • Endoscopic Sleeve Gastroplasty (ESG) Versus Laparoscopic Sleeve Gastroplasty (LSG): A Comparative Review
    Basil N Nduma, Kelly A Mofor, Jason Tatang, Loica Amougou, Stephen Nkeonye, Princess Chineme, Chukwuyem Ekhator, Solomon Ambe
    Cureus.2023;[Epub]     CrossRef
  • Operator-specific outcomes in endoscopic sleeve gastroplasty: a propensity-matched analysis of the US population using a multicenter database
    Hassam Ali, Faisal Inayat, Talia F. Malik, Pratik Patel, Gul Nawaz, Sobaan Taj, Attiq Ur Rehman, Arslan Afzal, Rizwan Ishtiaq, Muhammad Sohaib Afzal, Rashmi Advani, Rabindra R. Watson
    Baylor University Medical Center Proceedings.2023; 36(5): 592.     CrossRef
  • The surgical management of obesity
    Alan Askari, Periyathambi Jambulingam, Roy Gurprashad, Omer Al-Taan, Tanveer Adil, Aruna Munasinghe, Vigyan Jain, Farhan Rashid, Douglas Whitelaw
    Clinical Medicine.2023; 23(4): 330.     CrossRef
  • Endoluminal bariatric and metabolic therapies: state-of-the-art
    Nader Bakheet, Dilhana Badurdeen, Adrian Sartoretto, Vivek Kumbhari
    Current Opinion in Gastroenterology.2023; 39(5): 362.     CrossRef
  • Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons
    Shahab Shahabi Shahmiri, Chetan Parmar, Wah Yang, Panagiotis Lainas, Sjaak Pouwels, Amir Hossein DavarpanahJazi, Sonja Chiappetta, Yosuke Seki, Islam Omar, Ramon Vilallonga, Radwan Kassir, Syed Imran Abbas, Ahmad Bashir, Rishi Singhal, Lilian Kow, Mohamma
    BMC Surgery.2023;[Epub]     CrossRef
  • Summarizing Consensus Guidelines on Obesity Management
    Reem Z. Sharaiha, Scott Shikora, Kevin P. White, Guilherme Macedo, Jim Toouli, Lillian Kow
    Journal of Clinical Gastroenterology.2023; 57(10): 967.     CrossRef
  • Endoscopic sleeve gastroplasty reintervention score using supervised machine learning
    Hassam Ali, Pratik Patel, Talia Farrukh Malik, Rahul Pamarthy, Babu P. Mohan, Ravishankar Asokkumar, Gontrand Lopez-Nava, Douglas G. Adler
    Gastrointestinal Endoscopy.2023; 98(5): 747.     CrossRef
  • Endoscopic sleeve gastroplasty: results from a single surgical bariatric centre
    Lino Polese, Luca Prevedello, Amanda Belluzzi, Emilia Giugliano, Alice Albanese, Mirto Foletto
    Updates in Surgery.2022; 74(6): 1971.     CrossRef
  • Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
    Hee Kyong Na, Diogo Turiani Hourneaux De Moura
    Clinical Endoscopy.2021; 54(1): 25.     CrossRef
  • The Effect of Endoscopic Bariatric and Metabolic Therapies on Gastroesophageal Reflux Disease
    Su-Young Kim
    Medicina.2021; 57(8): 737.     CrossRef
  • 6,868 View
  • 252 Download
  • 13 Web of Science
  • 18 Crossref
Close layer
Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
Hee Kyong Na, Diogo Turiani Hourneaux De Moura, The Study Group for Endoscopic Bariatric and Metabolic Therapies of the Korean Society of Gastrointestinal Endoscopy
Clin Endosc 2021;54(1):25-31.   Published online January 29, 2021
DOI: https://doi.org/10.5946/ce.2021.021
AbstractAbstract PDFPubReaderePub
Obesity, along with its comorbidities, has become a significant public health concern worldwide. Bariatric surgery is considered the most effective treatment modality; however, only 2% of patients with obesity undergo bariatric surgery. Endoscopic bariatric and metabolic therapies (EBMTs) are emerging alternatives to traditional bariatric surgery for patients who are not eligible for or do not prefer surgical treatment. EBMTs are generally categorized as space-occupying, gastric restrictive, aspiration, and small bowel therapies. We aimed to review various non-balloon and non-gastroplasty devices with available clinical data and discuss the possible mechanisms of action, efficacy, and safety profile of these EMBTs.

Citations

Citations to this article as recorded by  
  • Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control
    Willian Ferreira Igi, Victor Lira de Oliveira, Ayah Matar, Diogo Turiani Hourneaux de Moura
    Clinical Endoscopy.2024; 57(3): 309.     CrossRef
  • Intragastric Balloons
    D.T.H. de Moura, Sergio A. Sánchez-Luna, Adriana Fernandes Silva, Alexandre Moraes Bestetti
    Gastrointestinal Endoscopy Clinics of North America.2024;[Epub]     CrossRef
  • Current State of Endoscopic Bariatric Therapies
    Lee Ying, Samuel Butensky, Ysabel Ilang-Ying, Saber Ghiassi
    Surgical Clinics of North America.2024;[Epub]     CrossRef
  • Effectiveness and Safety of the Allurion Swallowable Intragastric Balloon for Short-term Weight Loss: A Systematic Review and Meta-analysis
    Adriana Fernandes Silva, Alexandre Moraes Bestetti, Angelo So Taa Kum, Beanie Conceição Medeiros Nunes, Matheus de Oliveira Veras, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura
    Obesity Surgery.2024;[Epub]     CrossRef
  • The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Erika Yuki Yvamoto, Diogo Turiani Hourneaux de Moura, Igor Mendonça Proença, Epifanio Silvino do Monte Junior, Igor Braga Ribeiro, Pedro Henrique Boraschi Vieira Ribas, Matheus Cândido Hemerly, Victor Lira de Oliveira, Sergio A. Sánchez-Luna, Wanderley Ma
    Obesity Surgery.2023; 33(2): 585.     CrossRef
  • A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
    Aurelio Mauro, Francesca Lusetti, Davide Scalvini, Marco Bardone, Federico De Grazia, Stefano Mazza, Lodovica Pozzi, Valentina Ravetta, Laura Rovedatti, Carmelo Sgarlata, Elena Strada, Francesca Torello Viera, Letizia Veronese, Daniel Enrique Olivo Romero
    Medicina.2023; 59(3): 636.     CrossRef
  • Endoscopic Bariatric Therapy for Obesity and Metabolic Syndrome
    Sang Pyo Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(4): 247.     CrossRef
  • The Effect of Endoscopic Bariatric and Metabolic Therapies on Gastroesophageal Reflux Disease
    Su-Young Kim
    Medicina.2021; 57(8): 737.     CrossRef
  • 4,882 View
  • 160 Download
  • 5 Web of Science
  • 8 Crossref
Close layer
Reviews
Trends of Colorectal Cancer Prevalence in Kazakhstan Related to Screening
Alma Zhylkaidarova, Dilyara Kaidarova, Kanat Batyrbekov, Oxana Shatkovskaya, Dinara Begimbetova
Clin Endosc 2021;54(1):32-37.   Published online May 25, 2020
DOI: https://doi.org/10.5946/ce.2019.198
AbstractAbstract PDFPubReaderePub
We carried out an analysis of the total incidence of colon cancer throughout Kazakhstan. Retrospectively, according to the regional reports on endoscopic screening, the study showed an increase in the age-related incidence of colorectal cancer (CRC) cases from 2004–2008 to 2009–2014. The peak of morbidity in both periods was noted in the age category of >70 years. The indicators of the territorial distribution of CRC incidence make it possible to divide the regions into areas with low or high rates of CRC. Specific indicators showed newly diagnosed cases of CRC stages I, II, III, and IV in 2004–2018. The incidence rates of stages I and II showed a two-fold increase (35%–67.4%) and the incidence of stage IV showed a decline from 19.3% to 13.1% and of stage III from 45.7% to 19.5% from 2004 to 2018, respectively. An analysis of CRC incidence throughout Kazakhstan showed an increase in the overall incidence. Since population-based CRC screening was introduced in 2011, the morbidity was found to increase for stages I and II.

Citations

Citations to this article as recorded by  
  • Colorectal cancer’s burden attributable to a diet high in processed meat in the Belt and Road Initiative countries
    Gu Liu, Chang-Min Li, Fei Xie, Qi-Lai Li, Liang-Yan Liao, Wen-Jun Jiang, Xiao-Pan Li, Guan-Ming Lu
    World Journal of Gastrointestinal Oncology.2024; 16(1): 182.     CrossRef
  • Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer
    Constantin-Dan Tâlvan, Liviuța Budișan, Elena-Teodora Tâlvan, Valentin Grecu, Oana Zănoagă, Cosmin Mihalache, Victor Cristea, Ioana Berindan-Neagoe, Călin Ilie Mohor
    Cancers.2024; 16(4): 745.     CrossRef
  • Kazakh version of the beck depression inventory: Validation study in female cancer patients
    Indira Karibayeva, Botagoz Turdaliyeva, Nor Zuraida Zainal, Fatima Bagiyarova, Dinara Kussainova
    Heliyon.2023; 9(7): e18146.     CrossRef
  • Colorectal Cancer Screening with Computed Tomography Colonography: Single Region Experience in Kazakhstan
    Jandos Amankulov, Dilyara Kaidarova, Zhamilya Zholdybay, Marianna Zagurovskaya, Nurlan Baltabekov, Madina Gabdullina, Akmaral Ainakulova, Dias Toleshbayev, Alexandra Panina, Elvira Satbayeva, Zhansaya Kalieva
    Clinical Endoscopy.2022; 55(1): 101.     CrossRef
  • Association of four genetic variants with colorectal cancer in Kazakhstan population
    Yevgeniya Kolesnikova, Dmitriy Babenko, Irina Kadyrova, Svetlana Kolesnichenko, Lyudmila Akhmaltdinova, Ilya Korshukov, Naylya Kabildina, Valentina Sirota, Vera Zhumaliyeva, Dana Taizhanova, Dmitriy Vazenmiller, Anar Turmukhambetova
    Oncotarget.2021; 12(21): 2215.     CrossRef
  • 6,462 View
  • 167 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
The Role of Needle-Based Confocal Laser Endomicroscopy in the Evaluation of Pancreatic Cystic Lesions: A Systematic Review
Yung Ka Chin, Clement Chun Ho Wu, Damien Meng Yew Tan
Clin Endosc 2021;54(1):38-47.   Published online March 31, 2020
DOI: https://doi.org/10.5946/ce.2019.200-IDEN
AbstractAbstract PDFPubReaderePub
The prevalence of pancreatic cystic lesions (PCLs) has increased recently due to the increased use of cross-sectional abdominal imaging and the ageing global population. Current diagnostic techniques are inadequate to distinguish between PCLs that require surgery, close surveillance, or expectant management. This has resulted in increased morbidity from both inappropriately aggressive and conservative management strategies. Needle-based confocal laser endomicroscopy (nCLE) has allowed microscopic examination and visual delineation of the surface epithelium of PCLs. Landmark studies in this decade have correlated nCLE and histological findings and identified characteristics differentiating various types of PCLs. Subsequent studies have confirmed the high diagnostic yield of nCLE and its diagnostic utility in PCLs with an equivocal diagnosis. Moreover, nCLE has been shown to improve the diagnostic yield of PCLs. This will help avoid unnecessary pancreatic surgery, which carries significant morbidity and mortality risks. The early detection of high-grade dysplasia in PCLs will provide early surgical treatment and improve outcomes for pancreatic cancer. Despite the high upfront cost of nCLE, the improved diagnostic accuracy and resultant appropriate management have resulted in improved cost effectiveness. Refining the procedure technique and limiting the procedure length have significantly improved the safety of nCLE. A structured training program and device improvements to allow more complete mapping of the pancreatic cyst epithelium will be crucial for the widespread adoption of this promising technology.

Citations

Citations to this article as recorded by  
  • Molecular Pathology of Pancreatic Cystic Lesions with a Focus on Malignant Progression
    Yan Hu, Dan Jones, Ashwini K. Esnakula, Somashekar G. Krishna, Wei Chen
    Cancers.2024; 16(6): 1183.     CrossRef
  • Applications and Prospects of Artificial Intelligence-Assisted Endoscopic Ultrasound in Digestive System Diseases
    Jia Huang, Xiaofei Fan, Wentian Liu
    Diagnostics.2023; 13(17): 2815.     CrossRef
  • EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts
    Michele T. Yip-Schneider, Rodica Muraru, Rachel C. Kim, Howard H. Wu, Stuart Sherman, Aditya Gutta, Mohammad A. Al-Haddad, John M. Dewitt, C. Max Schmidt
    HPB.2023; 25(12): 1587.     CrossRef
  • Current trends in the management of pancreatic cystic neoplasms in Korea: a national survey
    Hyung Ku Chon, Sung Hoon Moon, Sang Wook Park, Woo Hyun Paik, Chang Nyol Paik, Byoung Kwan Son, Tae Jun Song, Dong Won Ahn, Eaum Seok Lee, Yun Nah Lee, Yoon Suk Lee, Jae Min Lee, Tae Joo Jeon, Chang-Hwan Park, Kwang Bum Cho, Dong Wook Lee
    The Korean Journal of Internal Medicine.2022; 37(1): 63.     CrossRef
  • Confocal Laser Endomicroscopy in the Diagnosis of Biliary and Pancreatic Disorders: A Systematic Analysis
    Do Han Kim, Somashekar G. Krishna, Emmanuel Coronel, Paul T. Kröner, Herbert C. Wolfsen, Michael B. Wallace, Juan E. Corral
    Clinical Endoscopy.2022; 55(2): 197.     CrossRef
  • Accuracy and agreement of a large panel of endosonographers for endomicroscopy-guided virtual biopsy of pancreatic cystic lesions
    Jorge D. Machicado, Bertrand Napoleon, Anne Marie Lennon, Samer El-Dika, Stephen P. Pereira, Damien Tan, Rahul Pannala, Mohit Girotra, Pradermchai Kongkam, Helga Bertani, Yunlu Feng, Hao Sijie, Ning Zhong, Vincent Valantin, Sarah Leblanc, Alice Hinton, So
    Pancreatology.2022; 22(7): 994.     CrossRef
  • Pancreatic Cystic Lesions: A Focused Review on Cyst Clinicopathological Features and Advanced Diagnostics
    Wei Chen, Nehaal Ahmed, Somashekar G. Krishna
    Diagnostics.2022; 13(1): 65.     CrossRef
  • Diagnostic Value of Endomicroscopy for Gastrointestinal Diseases: New Possibilities and Concepts
    Ralf Kiesslich
    Techniques and Innovations in Gastrointestinal Endoscopy.2021; 23(1): 57.     CrossRef
  • 5,682 View
  • 224 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Original Articles
Changes in Policy and Endoscopic Procedures during the 2019 Coronavirus Disease Outbreak: A Single Center Experience
Adi Lahat, Avidan Benjamin
Clin Endosc 2021;54(1):48-54.   Published online November 6, 2020
DOI: https://doi.org/10.5946/ce.2020.132
AbstractAbstract PDFPubReaderePub
Background
/Aims: The coronavirus disease-19 (COVID-19) pandemic forced endoscopy units to enact major changes on daily practice and policy. The Chaim Sheba Medical Center is a tertiary referral center located in the center of Israel, and serves cities with high infection rates. Our aim was to review the policies enacted during this outbreak and study their influence on the performance of endoscopic procedures.
Methods
Following the revision of work protocols, personnel were divided into two permanent and physically separate working groups and screening procedures were rescheduled. Relevant data including the number of endoscopic examinations, type of procedure performed, and patient referrals and indications were taken from a computerized database and evaluated. The study included data for January–March 2018–2020, and a comparison among the data from each year was performed.
Results
As of March 2020, the total number of endoscopic examinations performed reduced by 44% (p<0.0001) as compared to previous years, gastroscopy examinations reduced by 39% (p=0.02), and lower endoscopy procedures reduced by 57% (p<0.0001). Meanwhile, the number of advanced endoscopic procedures performed remained consistent with previous years. The indications for performance of gastroscopy and lower endoscopy were different in March 2020, while these remained unchanged for advanced endoscopic procedures.
Conclusions
The current policy appears to serve both our initial goals: protecting personnel and patients’ safety and minimizing potential damage from delayed endoscopic procedures. A longer term follow-up study is needed in order to fully analyze our results.

Citations

Citations to this article as recorded by  
  • Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability
    Muhammad Muntazir Mehdi Khan, Muhammad Musaab Munir, Selamawit Woldesenbet, Yutaka Endo, Mujtaba Khalil, Diamantis Tsilimigras, Alan Harzman, Emily Huang, Matthew Kalady, Timothy M. Pawlik
    Annals of Surgical Oncology.2024; 31(5): 3222.     CrossRef
  • Setting up a three‐stage pre‐endoscopy triage during the coronavirus disease 2019 pandemic: A multicenter observational study
    Tao‐Chieh Liu, Chen‐Ling Peng, Fang‐Yu Hsu, Li‐Chun Chang, Hsiu‐Po Wang, Wei‐Kuo Chang
    DEN Open.2023;[Epub]     CrossRef
  • Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review
    Afrooz Mazidimoradi, Azita Tiznobaik, Hamid Salehiniya
    Journal of Gastrointestinal Cancer.2022; 53(3): 730.     CrossRef
  • The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality
    Naim Abu-Freha, Reut Hizkiya, Muhammad Abu-Abed, Tal Michael, Binil Mathew Jacob, Keren Rouvinov, Doron Schwartz, Avraham Reshef, Uri Netz, Ilia Pinsk, Ohad Etzion
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • The Dramatic Change in Endoscopic Activities Following the Coronavirus Disease 2019 Outbreak. Is It Evolution?
    Kook Hyun Kim
    Clinical Endoscopy.2021; 54(3): 445.     CrossRef
  • Protecting Your Endoscopy Unit during the COVID-19 Pandemic
    Hyeong Ho Jo, Eun Young Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(3): 239.     CrossRef
  • Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool
    Adi Lahat, Ido Veisman
    Diagnostics.2021; 11(10): 1737.     CrossRef
  • 5,285 View
  • 125 Download
  • 6 Web of Science
  • 7 Crossref
Close layer
Confocal Laser Endomicroscopic Findings of Refractory Erosive Reflux Disease versus Non-Erosive Reflux Disease with Anti-Reflux Mucosectomy: An in vivo and ex vivo Study
Eunju Jeong, In Kyung Yoo, Abdullah Özgür Yeniova, Dong Keon Yon, Joo Young Cho
Clin Endosc 2021;54(1):55-63.   Published online May 7, 2020
DOI: https://doi.org/10.5946/ce.2020.040
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background
/Aims: To date, there is no standard tool to diagnose gastroesophageal reflux disease (GERD). Typically, GERD is a non-erosive reflux disease (NERD) that does not present endoscopic abnormalities. Confocal laser endomicroscopy (CLE) has been shown to be an effective tool to identify and diagnose GERD. We aimed to investigate the cellular and vascular changes in vivo and ex vivo through CLE in patients with GERD.
Methods
Patients with refractory GERD who underwent mucosectomy were recruited. The distal esophagus was observed in vivo using CLE. Mucosectomy tissue was stained with acriflavine and CLE image was obtained ex vivo. We compared cellular and vascular changes in CLE between erosive reflux disease (ERD), NERD, and a control group.
Results
Eleven patients who underwent anti-reflux mucosectomy and five control patients were enrolled in the study. Patients with ERD and NERD presented greater dilated intercellular space than patients in the control group on CLE image. The diameter, number, and cross-sectional area of the intra-papillary capillary loops (IPCLs) were significantly larger in the ERD group than in the NERD group. The irregular shape of the IPCLs were observed in both patients with ERD and NERD.
Conclusions
The irregular shape of the IPCLs were significantly correlated with a positive diagnosis of GERD. CLE may diagnose NERD with high sensitivity and accuracy.

Citations

Citations to this article as recorded by  
  • Outcomes of Endoscopic Antireflux Mucosectomy for the Treatment of Gastroesophageal Reflux Disease
    Martin Galvarini, Cristian A. Angeramo, Javier Kerman, Rubén Balmaceda, Ignacio Debes, Fernando A.M. Herbella, Francisco Schlottmann
    Journal of Clinical Gastroenterology.2024; 58(9): 851.     CrossRef
  • Anti-reflux mucosal resection for treatment of refractory gastro-oesophageal reflux disease: Efficacy and impact on perioperative indicators
    Xing-Feng Ge, Xian Zhu, Fei Min, Jian-Wei Shen
    World Chinese Journal of Digestology.2023; 31(4): 157.     CrossRef
  • 6,686 View
  • 193 Download
  • 2 Crossref
Close layer
Efficacy of the Envelope Method in Applying Polyglycolic Acid Sheets to Post-Endoscopic Submucosal Dissection Ulcers in Living Pigs
Hiroya Sakaguchi, Toshitatsu Takao, Yoshitaka Takegawa, Yuki Koga, Kazunori Yamanaka, Masataka Sagata, Shinwa Tanaka, Yoshinori Morita, Takashi Toyonaga, Yuzo Kodama
Clin Endosc 2021;54(1):64-72.   Published online July 16, 2020
DOI: https://doi.org/10.5946/ce.2020.014
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background
/Aims: Application of polyglycolic acid (PGA) sheets using fibrin glue in post-endoscopic submucosal dissection (ESD) ulcers to prevent bleeding has been reported to be difficult with the conventional delivery method because of gravity. This study assessed the usefulness of the envelope-based delivery system with and against gravity in living pigs.
Methods
PGA sheets were applied on post-ESD ulcers with and against gravity six times each using the conventional and envelope methods, respectively. The PGA sheet delivery time and the endoscopic and histological findings of the treated ulcer floors were compared.
Results
With gravity, the median PGA sheet application time was 1.00 (0.68–1.30) min/cm2 and 0.32 (0.18–0.52) min/cm2 with the conventional and envelope techniques (p=0.002), respectively, and against gravity, it was 1.20 (1.13–1.63) min/cm2 and 0.50 (0.39–0.58) min/cm2 (p=0.002), respectively. Against gravity, the endoscopic and histological findings revealed that the conventional group had insufficient fixation of the PGA sheets, but the envelope groups had sufficient fixation. The results with gravity were similar between the groups.
Conclusions
The envelope method makes it possible to deliver PGA sheets to the stomach quickly and cover ulcers appropriately both with and against gravity in living pigs.

Citations

Citations to this article as recorded by  
  • Endoscopic sealing hemostasis with polyglycolic acid sheet and fibrin glue as a novel endoscopic hemostatic technique: a report of three cases
    Kai Korekawa, Atsushi Kunimitsu
    Clinical Journal of Gastroenterology.2024; 17(4): 626.     CrossRef
  • Clinical Impact of Different Reconstruction Methods on Remnant Gastric Cancer at the Anastomotic Site after Distal Gastrectomy
    Kei Matsumoto, Shinwa Tanaka, Takashi Toyonaga, Nobuaki Ikezawa, Mari Nishio, Masanao Uraoka, Tomoatsu Yoshihara, Hiroya Sakaguchi, Hirofumi Abe, Tetsuya Yoshizaki, Madoka Takao, Toshitatsu Takao, Yoshinori Morita, Hiroshi Yokozaki, Yuzo Kodama
    Clinical Endoscopy.2022; 55(1): 86.     CrossRef
  • The importance of pH adjustment for preventing fibrin glue dissolution in the stomach: an in vitro study
    Yoshitaka Takegawa, Toshitatsu Takao, Hiroya Sakaguchi, Tatsuya Nakai, Kazuhiro Takeo, Yoshinori Morita, Takashi Toyonaga, Yuzo Kodama
    Scientific Reports.2022;[Epub]     CrossRef
  • A Novel Self-Assembled Gel for Gastric Endoscopic Submucosal Dissection-Induced Ulcer: A Preclinical Study in a Porcine Model
    Meng Li, Haifeng Jin, Changpei Shi, Bin Lyu, Xiao Ying, Yuan Shi
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • 5,150 View
  • 120 Download
  • 5 Web of Science
  • 4 Crossref
Close layer
Endoscopic Characteristics of Rugal Hyperplasia and Related Acid Condition in Helicobacter pylori-Infected Stomach
Byung Chul Kim, Mi Ae Song, Sung Ho Kwon
Clin Endosc 2021;54(1):73-84.   Published online December 15, 2020
DOI: https://doi.org/10.5946/ce.2020.020
AbstractAbstract PDFPubReaderePub
Background
/Aims: Rugal hyperplastic gastritis (RHG) is associated with Lauren’s diffuse-type gastric cancer (GC) and the accompanying active inflammation is linked to gastric hypoacidity. We tried to establish the steps for identifying high-risk GC patients.
Methods
We included 196 patients with confirmed Helicobacter pylori infection by rapid urease test during screening endoscopy for health check-up from January 2016 to September 2016; all patients underwent blood tests for pepsinogen I and II and fasting serum gastrin. We compared RHG findings with various other endoscopic mucosal images. We also evaluated the relationships between RHG and other mucosal aspects for a given acid status based on serological markers.
Results
Hypoacid and ultra-low-acid (67%) statuses were dominant, with only 18% hyperacid patients. RHG with high acid was related to a less atrophic body type (p=0.001), and RHG with ultra-low acid was associated with body xanthoma (p=0.029) and increased serum gastrin level (p=0.038). However, RHG’s influence on gastric acidity was only seen in closed-type endoscopic atrophic border (EAB), not in open type (p=0.001).
Conclusions
The majority of RHG patients had hypoacid status. RHG frequency showed no difference between closed and opentype EAB, but gastric acidity was influenced by RHG only in closed-type EAB.

Citations

Citations to this article as recorded by  
  • Cancer risk stratification system and classification of gastritis: Perspectives
    Sergey M Kotelevets, Sergey A Chekh, Sergey Z Chukov
    World Journal of Meta-Analysis.2023; 11(1): 18.     CrossRef
  • Risk factors for early gastric cancer: focus on Helicobacter pylori gastritis
    Hee Seok Moon
    Journal of the Korean Medical Association.2022; 65(5): 259.     CrossRef
  • Giant Rugae in Helicobacter pylori-Infected Stomachs
    Sun-Young Lee
    Clinical Endoscopy.2021; 54(1): 1.     CrossRef
  • 4,561 View
  • 126 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Clinicopathological Features of Small Bowel Tumors Diagnosed by Video Capsule Endoscopy and Balloon-Assisted Enteroscopy: A Single Center Experience
Ah Young Yoo, Beom Jae Lee, Won Shik Kim, Seong Min Kim, Seung Han Kim, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park
Clin Endosc 2021;54(1):85-91.   Published online August 31, 2020
DOI: https://doi.org/10.5946/ce.2020.047
AbstractAbstract PDFPubReaderePub
Background
/Aims: Small bowel malignancies often present a diagnostic challenge due to their relative rarity and nonspecific clinical symptoms. However, technical developments in endoscopic instruments, including video capsule endoscopy (VCE) and enteroscopy, have allowed for the visualization of the entire small bowel. This study aimed to investigate the clinicopathological features of small bowel malignant tumors diagnosed by VCE and double-balloon enteroscopy (DBE) in a single tertiary center.
Methods
We retrospectively analyzed VCE and DBE findings from Korea University Guro Hospital from January 2010 through September 2018.
Results
A total of 510 VCE and 126 DBE examinations were performed in 438 patients. Small bowel malignancies were diagnosed in 28 patients (15 males; mean age, 61.0 years; range, 42 to 81 years). Among them, 8 had lymphoma, 8 had primary adenocarcinoma, 7 had gastrointestinal stromal tumor (GIST) and 5 had metastatic cancer. Abdominal pain and obstructive symptoms were the most common findings in metastatic cancers (4/5, 80%). On the other hand, obscure gastrointestinal bleeding was the most common symptom of GIST (6/7, 85.7%) and adenocarcinoma (3/8, 37.5%).
Conclusions
Approximately 6% of the patients who underwent either VCE or DBE were diagnosed with small bowel malignancy. These findings demonstrated the different clinical characteristics among small bowel malignancies and merit further study.

Citations

Citations to this article as recorded by  
  • Prognostic factors for liver metastasis in patients with small intestinal stromal tumor: A retrospective analysis of surveillance, epidemiology, and end results
    Luojie Liu, Rufa Zhang, Zhenguo Qiao, Ye Ye, Kaijian Xia, Yunfu Feng, Xiaodan Xu
    World Journal of Surgery.2024; 48(3): 598.     CrossRef
  • A practical approach for small bowel bleeding
    Sung Eun Kim, Hyun Jin Kim, Myeongseok Koh, Min Cheol Kim, Joon Sung Kim, Ji Hyung Nam, Young Kwan Cho, A Reum Choe
    Clinical Endoscopy.2023; 56(3): 283.     CrossRef
  • Clinicopathological characteristics and prognostic factors of small bowel lymphomas: a retrospective single-center study
    Emanuel Dias, Renato Medas, Margarida Marques, Patrícia Andrade, Hélder Cardoso, Guilherme Macedo
    Porto Biomedical Journal.2023;[Epub]     CrossRef
  • Small Bowel Capsule Endoscopy and Enteroscopy: A Shoulder-to-Shoulder Race
    Ana-Maria Singeap, Catalin Sfarti, Horia Minea, Stefan Chiriac, Tudor Cuciureanu, Robert Nastasa, Carol Stanciu, Anca Trifan
    Journal of Clinical Medicine.2023; 12(23): 7328.     CrossRef
  • Symptoms Contributing to the Diagnosis of Small Bowel Tumors
    Kozo Tsuruta, Hidetoshi Takedatsu, Shinichiro Yoshioka, Masahiro Yoshikai, Kensuke Tomiyasu, Masaru Morita, Kotaro Kuwaki, Keiichi Mitsuyama, Takumi Kawaguchi
    Digestion.2023; 104(6): 430.     CrossRef
  • Small bowel lymphoma: clinical update and challenges for the gastroenterologist
    Priya Oka, Reena Sidhu
    Current Opinion in Gastroenterology.2022; 38(3): 270.     CrossRef
  • Indication, Location of the Lesion, Diagnostic Yield, and Therapeutic Yield of Double-Balloon Enteroscopy: Seventeen Years of Experience
    Sang Pyo Lee, Hyun Joo Jang, Sea Hyub Kae, Jae Gon Lee, Ji Hye Kwon
    Diagnostics.2022; 12(9): 2224.     CrossRef
  • Minimally invasive surgery with adenocarcinoma of jejunum diagnosed pathologically before surgery: A case report
    Sung Chul Lee
    International Journal of Surgery Case Reports.2021; 79: 354.     CrossRef
  • Predictors of Positive Video Capsule Endoscopy Findings for Chronic Unexplained Abdominal Pain: Single-Center Retrospective Study and Meta-Analysis
    Wonshik Kim, Beomjae Lee, Ahyoung Yoo, Seunghan Kim, Moonkyung Joo, Jong-Jae Park
    Diagnostics.2021; 11(11): 2123.     CrossRef
  • Small Bowel Malignancies in Patients Undergoing Capsule Endoscopy for Iron Deficiency Anemia
    Su Hwan Kim, Ji Won Kim
    Diagnostics.2021; 12(1): 91.     CrossRef
  • 4,487 View
  • 176 Download
  • 11 Web of Science
  • 10 Crossref
Close layer
Colon Capsule Endoscopy: Indications, Findings, and Complications – Data from a Prospective German Colon Capsule Registry Trial (DEKOR)
Johannes Hausmann, Andrea Tal, Artur Gomer, Michael Philipper, Gero Moog, Horst Hohn, Norbert Hesselbarth, Harald Plass, Jörg Albert, Fabian Finkelmeier
Clin Endosc 2021;54(1):92-99.   Published online June 18, 2020
DOI: https://doi.org/10.5946/ce.2020.049
AbstractAbstract PDFPubReaderePub
Background
/Aims: Reliable and especially widely accepted preventive measures are crucial to further reduce the incidence of colorectal cancer (CRC). Colon capsule endoscopy (CCE) might increase the screening numbers among patients unable or unwilling to undergo conventional colonoscopy. This registry trial aimed to document and determine the CCE indications, findings, complications, and adverse events in outpatient practices and clinics throughout Germany.
Methods
Patients undergoing CCE between 2010 and 2015 were enrolled in this prospective multicenter registry trial at six German centers. Patient demographics, outcomes, and complications were evaluated.
Results
A total of 161 patients were included. Of the CCE evaluations, 111 (68.9%) were considered successful. Pathological findings in the colon (n=92, 60.1%) and in the remaining gastrointestinal tract (n=38, 24.8%) were recorded. The main finding was the presence of polyps (n=52, 32.3%). Furthermore, five carcinomas (3.1%) were detected and histologically confirmed later. Adequate bowel cleanliness was more likely to be achieved in the outpatient setting (p<0.0001). Interestingly, 85 patients (55.6%) chose to undergo CCE based on personal motivation.
Conclusions
CCE seems to be a reliable and safe endoscopic tool for screening for CRC and detecting other diseases. Its patient acceptance and feasibility seems to be high, especially in the outpatient setting.

Citations

Citations to this article as recorded by  
  • Advances in colon capsule endoscopy: a review of current applications and challenges
    E. Gibbons, O. B. Kelly, B. Hall
    Frontiers in Gastroenterology.2023;[Epub]     CrossRef
  • Computer-Aided Diagnosis of Gastrointestinal Protruded Lesions Using Wireless Capsule Endoscopy: A Systematic Review and Diagnostic Test Accuracy Meta-Analysis
    Hye Jin Kim, Eun Jeong Gong, Chang Seok Bang, Jae Jun Lee, Ki Tae Suk, Gwang Ho Baik
    Journal of Personalized Medicine.2022; 12(4): 644.     CrossRef
  • Colon Capsule Endoscopy in the Diagnosis of Colon Polyps: Who Needs a Colonoscopy?
    Apostolos Koffas, Apostolis Papaefthymiou, Faidon-Marios Laskaratos, Andreas Kapsoritakis, Owen Epstein
    Diagnostics.2022; 12(9): 2093.     CrossRef
  • The Effectiveness of a Very Low-Volume Compared to High-Volume Laxative in Colon Capsule Endoscopy
    Benedicte Schelde-Olesen, Artur Nemeth, Gabriele Wurm Johansson, Ulrik Deding, Thomas Bjørsum-Meyer, Henrik Thorlacius, Gunnar Baatrup, Anastasios Koulaouzidis, Ervin Toth
    Diagnostics.2022; 13(1): 18.     CrossRef
  • Colon Capsule Endoscopy: An Alternative for Conventional Colonoscopy?
    Britt B.S.L. Houwen, Evelien Dekker
    Clinical Endoscopy.2021; 54(1): 4.     CrossRef
  • Examination of Entire Gastrointestinal Tract: A Perspective of Mouth to Anus (M2A) Capsule Endoscopy
    Ji Hyung Nam, Kwang Hoon Lee, Yun Jeong Lim
    Diagnostics.2021; 11(8): 1367.     CrossRef
  • 6,402 View
  • 177 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with Meta-Analysis
Byung Hyo Cha, Myoung-Jin Jang, Sang Hyub Lee
Clin Endosc 2021;54(1):100-106.   Published online January 15, 2021
DOI: https://doi.org/10.5946/ce.2020.254
AbstractAbstract PDFPubReaderePub
Background
/Aims: Cholangiocarcinoma (CCA) is a rare but aggressive disease with a poor survival. Recent trials have shown improved survival with intraductal radiofrequency ablation (RFA) therapy. We performed a systematic review with meta-analysis to determine the survival benefit of endoscopic RFA for unresectable extrahepatic CCA with malignant biliary obstruction (MBO).
Methods
A systematic search from 1970 to 2020 was performed in MEDLINE, EMBASE, Cochrane Library, and ClinicalTrials. gov. We selected eligible studies reporting relative risks, hazard ratios (HRs), or odds ratios, adjusted by controlling for confounding factors of survival rate and stent patency duration, among patients with extrahepatic CCA with MBO treated with RFA with stent insertion or stent insertion only.
Results
A total of eight trials (three randomized and five nonrandomized) with a total of 420 patients were included in the metaanalysis. Pooled overall survival analysis favored RFA treatment with stent insertion (HR, 0.47; 95% confidence interval [CI], 0.34– 0.64; I2=47%; p=0.09); however, no significant difference was found in the duration of stent patency between the groups (HR, 0.79; 95% CI, 0.57–1.09; I2=7%; p=0.36).
Conclusions
RFA therapy with stent insertion may confer a survival benefit compared with stent insertion only in patients with CCA and MBO.

Citations

Citations to this article as recorded by  
  • Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis
    Matheus de Oliveira Veras, Diogo Turiani Hourneaux de Moura, Thomas R. McCarty, Guilherme Henrique Peixoto de Oliveira, Rômulo Sérgio Araújo Gomes, Davi Lucena Landim, Felipe Giacobo Nunes, Tomazo Antônio Prince Franzini, Marcos Eduardo Lera dos Santos, W
    Endoscopy International Open.2024; 12(01): E23.     CrossRef
  • Reply to Chandrasekhara and Aggarwal
    Matheus de Oliveira Veras, Diogo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux de Moura
    Endoscopy International Open.2024; 12(05): E640.     CrossRef
  • Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures

    Journal of Digestive Diseases.2024; 25(1): 2.     CrossRef
  • The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Daniele Balducci, Michele Montori, Francesco Martini, Marco Valvano, Federico De Blasio, Maria Eva Argenziano, Giuseppe Tarantino, Antonio Benedetti, Emanuele Bendia, Marco Marzioni, Luca Maroni
    Cancers.2024; 16(7): 1372.     CrossRef
  • Impact of temperature-controlled endobiliary radiofrequency ablation for inoperable hilar cholangiocarcinoma: A propensity score–matched analysis
    Il Sang Shin, Jong Ho Moon, Yun Nah Lee, Jun Ho Myeong, Tae Hoon Lee, Jae Kook Yang, Young Deok Cho, Sang-Heum Park
    Endoscopy International Open.2024; 12(04): E535.     CrossRef
  • Percutaneous endobiliary radiofrequency ablation and stent placement for unresectable malignant biliary obstruction: a propensity score matching retrospective study
    Wei Cui, Jing-Zhi Huang, Qi Wang, Feng Shi, Qing Gou, Xiao-Ming Chen, Jing Zhang, Jia-Ping Li, Rongde Xu
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Feasibility and safety of trans-biliary cryoablation: Preclinical evaluation of a novel flexible cryoprobe
    Chao Zhang, Linzhong Zhu, Shousheng Tang, Jukun Wang, Yu Li, Xin Chen, Chunjing Bian, Dongbin Liu, Guokun Ao, Tao Luo
    Cryobiology.2023; 111: 40.     CrossRef
  • Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures
    Hayat Khizar, Yufei Hu, Yanhua Wu, Kamran Ali, Junaid Iqbal, Muhammad Zulqarnain, Jianfeng Yang
    Journal of Clinical Gastroenterology.2023; 57(4): 335.     CrossRef
  • Development of novel biliary metal stent with coil-spring structure and its application in vivo swine biliary stricture model
    In Rae Cho, Sang Hyub Lee, Jin Ho Choi, Namyoung Park, Min Woo Lee, Joo Seong Kim, Seok Jeong, Don Haeng Lee, Tae-Won Jeong, Byoung-Yun Ki, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • In-stent radiofrequency ablation with uncovered metal stent placement for tumor ingrowth/overgrowth causing self-expandable metal stent occlusion in distal malignant biliary obstruction: multicenter propensity score–matched study
    Namyoung Park, Min Kyu Jung, Eui Joo Kim, Woo Hyun Paik, Jae Hee Cho
    Gastrointestinal Endoscopy.2023; 97(4): 694.     CrossRef
  • ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures
    B. Joseph Elmunzer, Jennifer L. Maranki, Victoria Gómez, Anna Tavakkoli, Bryan G. Sauer, Berkeley N. Limketkai, Emily A. Brennan, Elaine M. Attridge, Tara J. Brigham, Andrew Y. Wang
    American Journal of Gastroenterology.2023; 118(3): 405.     CrossRef
  • Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis
    Zahid Ijaz Tarar, Umer Farooq, Mustafa Gandhi, Ghulam Ghous, Saad Saleem, Faisal Kamal, Zaid Imam, Laith Jamil
    European Journal of Gastroenterology & Hepatology.2023; 35(6): 646.     CrossRef
  • Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
    Elena Di Girolamo, Andrea Belli, Alessandro Ottaiano, Vincenza Granata, Valentina Borzillo, Luca Tarotto, Fabiana Tatangelo, Raffaele Palaia, Corrado Civiletti, Mauro Piccirillo, Valentina D’Angelo, Francesco Fiore, Pietro Marone, Guglielmo Nasti, Frances
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial
    Jana Jarosova, Lea Zarivnijova, Ivana Cibulkova, Jan Mares, Peter Macinga, Alzbeta Hujova, Premysl Falt, Ondrej Urban, Jan Hajer, Julius Spicak, Tomas Hucl
    Gut.2023; 72(12): 2286.     CrossRef
  • Is endoscopic radiofrequency ablation plus stent placement superior to stent placement alone for the treatment of malignant biliary obstruction? A systematic review and meta-analysis
    Chenming Liu, Jiaming Dong, Yuxing Liu, Siyuan Zhang, Ruanchang Chen, Haijun Tang
    Journal of International Medical Research.2023;[Epub]     CrossRef
  • Intraductal Therapies for Cholangiocarcinoma
    Abhishek Agnihotri, David E. Loren
    Techniques and Innovations in Gastrointestinal Endoscopy.2022; 24(2): 200.     CrossRef
  • Silver Nanofunctionalized Stent after Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth
    Yubeen Park, Dong-Sung Won, Ga-Hyun Bae, Dae Sung Ryu, Jeon Min Kang, Ji Won Kim, Song Hee Kim, Chu Hui Zeng, Wooram Park, Sang Soo Lee, Jung-Hoon Park
    Pharmaceutics.2022; 14(2): 412.     CrossRef
  • Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis
    David M. de Jong, Jeska A. Fritzsche, Amber S. Audhoe, Suzanne S. L. Yi, Marco J. Bruno, Rogier P. Voermans, Lydi M. J. W. van Driel
    Cancers.2022; 14(9): 2079.     CrossRef
  • Evaluation and Management of Malignant Biliary Obstruction
    Nadia V. Guardado, Kaysey Llorente, Benoit Blondeau
    Surgical Oncology Clinics of North America.2021; 30(3): 491.     CrossRef
  • 4,550 View
  • 156 Download
  • 19 Web of Science
  • 19 Crossref
Close layer
Increased Risk of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography Following a Positive Intraoperative Cholangiogram: A Single-Center Experience
Lalitha M. Sitaraman, Rita M. Knotts, Judith Kim, Srihari Mahadev, David S. Lee
Clin Endosc 2021;54(1):107-112.   Published online July 15, 2020
DOI: https://doi.org/10.5946/ce.2020.025
AbstractAbstract PDFPubReaderePub
Background
/Aims: To determine if patients with a positive intraoperative cholangiogram (IOC) who undergo a subsequent endoscopic retrograde cholangiopancreatography (ERCP) have an increased risk of post-ERCP pancreatitis (PEP) compared to those who undergo ERCP directly for suspected common bile duct stones.
Methods
A retrospective case-control study was performed from 2010 to 2016. Cases included inpatients with a positive IOC at cholecystectomy who underwent subsequent ERCP. The control group included age-sex matched cohorts who underwent ERCP for choledocholithiasis. Multivariate logistic regression was used to assess the association between PEP and positive IOC, adjusting for matching variables and additional potential confounders.
Results
Of the 116 patients that met the inclusion criteria, there were 91 women (78%) in each group. Nine patients (7.8%) developed PEP in the IOC group, compared to 3 patients in the control group (2.6%). The use of pancreatic duct stents and rectal indomethacin was similar in both groups. After adjusting for age, sex, total bilirubin levels, and any stent placement, patients with a positive IOC had a significantly increased risk of PEP (odds ratio, 4.79; 95% confidence interval, 1.05–21.89; p<0.05).
Conclusions
In this single-center case-control study, there was a five-fold increased risk of PEP following a positive IOC compared to an age-sex matched cohort.

Citations

Citations to this article as recorded by  
  • Is Routine Intraoperative Cholangiogram Necessary in Patients With Mild Acute Biliary Pancreatitis Undergoing Index Admission Cholecystectomy?
    Natalie M Quarmby, Minh Tu Vo, Sivakumar Gananadha
    The American Surgeon™.2024;[Epub]     CrossRef
  • Accuracy of intraoperative cholangiography and outcomes of ERCP in hospitalized patients with suspected choledocholithiasis
    Masuma Syed, Sanghee K. Choi, Nikhil Thiruvengadam, Kendrick Che, Paul Leonor, Esther Wu, Maryam B. Tabrizi, Jeffrey Kim, Stephen Min, James Scheiman, John J. Kim
    iGIE.2023; 2(2): 117.     CrossRef
  • Endoscopic retrograde cholangiopancreatography is not necessary in all patients with an abnormal intraoperative cholangiogram
    Andrawus Beany, Anandpreet S Ghataura, Shaanan T E Yong, Kee F Loo, Rajvinder Singh, Biju George, Mohamed A Chinnaratha
    JGH Open.2023; 7(11): 797.     CrossRef
  • Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment
    Dong Kee Jang, Jungmee Kim, Chang Nyol Paik, Jung‐Wook Kim, Tae Hee Lee, Jae‐Young Jang, Seung Bae Yoon, Jun Kyu Lee
    United European Gastroenterology Journal.2022; 10(1): 73.     CrossRef
  • 3,811 View
  • 96 Download
  • 3 Web of Science
  • 4 Crossref
Close layer
Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms
Ibrahim Hakkı Köker, Nurcan Ünver, Fatma Ümit Malya, Ömer Uysal, Elmas Biberci Keskin, Hakan Şentürk
Clin Endosc 2021;54(1):113-121.   Published online December 11, 2020
DOI: https://doi.org/10.5946/ce.2020.083
AbstractAbstract PDFPubReaderePub
Background
/Aims: The role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating mucinous pancreatic cystic lesions (PCLs) is controversial. We investigated the role of cyst fluid CEA in differentiating low-risk (LR)-intraductal papillary mucinous neoplasms (IPMNs) from high-risk (HR)-IPMNs and LR-mucinous cystic neoplasms (MCNs).
Methods
This was a retrospective study of 466 patients with PCLs who underwent endoscopic ultrasound-guided fine-needleaspiration over a 7-year period. On histology, low-grade dysplasia and intermediate-grade dysplasia were considered LR, whereas high-grade dysplasia and invasive carcinoma were considered HR.
Results
Data on cyst fluid CEA levels were available for 50/102 mucinous PCLs with definitive diagnoses. The median CEA (range) levels were significantly higher in HR cysts than in LR cysts (2,624 [0.5–266,510] ng/mL vs. 100 [16.8–53,445]ng/mL, p=0.0012). The area under the receiver operating characteristic curve (AUROC) was 0.930 (95% confidence interval [CI], 0.5–0.8; p<0.001) for differentiating LR-IPMNs from LR-MCNs. The AUROC was 0.921 (95% CI, 0.823–1.000; p<0.001) for differentiating LR-IPMNs from HR-IPMNs. Both had a CEA cutoff level of >100ng/mL, with a negative predictive value (NPV) of 100%.
Conclusions
Cyst fluid CEA levels significantly vary between LR-IPMNs, LR-MCNs, and HR-IPMNs. A CEA cutoff level of >100ng/mL had a 100% NPV in differentiating LR-IPMNs from LR-MCNs and HR-IPMNs.

Citations

Citations to this article as recorded by  
  • Spectrum of MRI Features of Mucin-producing Neoplasms in the Abdomen and Pelvis
    Pei-Kang Wei, Mamta Gupta, Leo L. Tsai, Karen S. Lee, Adrian M. Jaramillo, Martin P. Smith, Jordan D. LeGout, Anuradha S. Shenoy-Bhangle
    RadioGraphics.2022; 42(2): 469.     CrossRef
  • Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?
    Ahmad Najdat Bazarbashi, Linda S. Lee
    Clinical Endoscopy.2021; 54(1): 7.     CrossRef
  • Deep Learning-Based Differentiation between Mucinous Cystic Neoplasm and Serous Cystic Neoplasm in the Pancreas Using Endoscopic Ultrasonography
    Leang Sim Nguon, Kangwon Seo, Jung-Hyun Lim, Tae-Jun Song, Sung-Hyun Cho, Jin-Seok Park, Suhyun Park
    Diagnostics.2021; 11(6): 1052.     CrossRef
  • 4,030 View
  • 127 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Case Reports
Esophageal Stricture Caused by the Ingestion of Undissolved Picosulfate Powder
Daehyun Kim, Byungha Cho, Jong Wook Choi, Ki Bae Kim, Seon Mee Park
Clin Endosc 2021;54(1):122-126.   Published online March 16, 2020
DOI: https://doi.org/10.5946/ce.2019.206
AbstractAbstract PDFPubReaderePub
Picosulfate solution is widely used as a small volume bowel cleansing agent and is considered to be effective and relatively safe. A case of a 75-year-old woman ingested picosulfate powder and drank a small volume of water, subsequently experienced severe burning pain in the chest. Endoscopy was performed and showed a submucosal hemorrhage and exudative ulcers at the mid to lower esophagus. At 2 weeks, her symptoms improved with conservative treatment. However, liquid food dysphagia developed 11 weeks after ingestion. A follow-up endoscopy revealed multiple esophageal strictures, which were treated with a fully covered metal stent and esophageal balloon dilation. Consequently, the esophageal strictures improved after one year. As this case demonstrates, detailed information about picosulfate powder ingestion after dissolving it in more than 200 mL of water should be presented to patients to avoid esophageal injury.

Citations

Citations to this article as recorded by  
  • Citric acid/magnesium oxide/sodium picosulfate

    Reactions Weekly.2021; 1868(1): 140.     CrossRef
  • 5,880 View
  • 144 Download
  • 1 Crossref
Close layer
Hybrid Peroral Endoscopic Myotomy for Achalasia with Prior Treatment Failure
In Kyung Yoo, Abdullah OzgurYeniova, Joo Young Cho
Clin Endosc 2021;54(1):127-130.   Published online April 2, 2020
DOI: https://doi.org/10.5946/ce.2020.013
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Achalasia is a neurodegenerative motility disorder caused by enteric neuron damage in the lower esophageal sphincter. Peroral endoscopic myotomy (POEM) is a standard treatment method for achalasia. Previous treatment modalities may affect the outcome of POEM as they cause submucosal fibrosis. We report a new technique called “hybrid POEM” for the treatment of patients with achalasia who had been previously treated with pneumatic balloon dilatation. We performed two techniques of POEM simultaneously, the standard POEM for the upper part of the submucosal tunnel and open POEM for the stenotic part of the esophagogastric junction. We dissected the mucosa and submucosa, and performed myotomy simultaneously. We overcame submucosal fibrosis of the esophagogastric junction, which was caused by the previous hybrid POEM treatment. The risks of mucosal incision and technical challenge of submucosal tunneling for the fibrotic area may be reduced by hybrid POEM.
  • 4,242 View
  • 136 Download
Close layer
Endoscopic Full-Thickness Resection for Gastric Subepithelial Lesions Arising from the Muscularis Propria
Ah Lon Jung, Sang Wook Park, Gun Young Hong, Hyeong Chul Moon, Seo Joon Eun
Clin Endosc 2021;54(1):131-135.   Published online August 21, 2020
DOI: https://doi.org/10.5946/ce.2020.070
AbstractAbstract PDFPubReaderePub
Most cases of gastric subepithelial lesions follow a good clinical course; however, some lesions progress to malignant tumors, and treatment of tumors with a high risk of malignancy is essential. Surgical excision has been the primary treatment for tumors originating from the propria muscle layer, but it has the disadvantages of being invasive and causing postoperative functional abnormalities. With the development of endoscopic techniques and instruments, the role of endoscopic resection, which is a less invasive method for the removal of gastric subepithelial lesions, has been attracting attention. We performed an endoscopic full-thickness resection for 8 patients with gastric subepithelial lesions originating from the muscularis propria. No fatal complications occurred. Our findings suggest the need to develop various devices for resection and closure and to accumulate further experience through additional studies to prevent complications and specimen loss.

Citations

Citations to this article as recorded by  
  • Robotic Platforms for Therapeutic Flexible Endoscopy: A Literature Review
    Naoya Tada, Kazuki Sumiyama
    Diagnostics.2024; 14(6): 595.     CrossRef
  • Advances of endoscopic and surgical management in gastrointestinal stromal tumors
    Lei Yue, Yingchao Sun, Xinjie Wang, Weiling Hu
    Frontiers in Surgery.2023;[Epub]     CrossRef
  • Current Status of Endoscopic Full-Thickness Resection for Gastric Subepithelial Tumors: A Literature Review Over Two Decades
    Naoya Tada, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Tsutomu Masaki, Noriya Uedo
    Digestion.2023; 104(6): 415.     CrossRef
  • Endoscopic Full Thickness Resection: A Systematic Review
    Partha Pal, Mohan Ramchandani, Pradev Inavolu, Duvvuru Nageshwar Reddy, Manu Tandan
    Journal of Digestive Endoscopy.2022; 13(03): 152.     CrossRef
  • 4,437 View
  • 120 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
Brief Reports
Linked Color Imaging Demonstrates Characteristic Findings in Semi-Pedunculated Gastric Adenocarcinoma in Helicobacter pylori-Negative Normal Mucosa
Yuji Hiraoka, Yoshimasa Miura, Hiroyuki Osawa, Mio Sakaguchi, Masato Tsunoda, Alan Kawarai Lefor, Hironori Yamamoto
Clin Endosc 2021;54(1):136-138.   Published online August 21, 2020
DOI: https://doi.org/10.5946/ce.2020.059
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • The Diagnostic Performance of Linked Color Imaging Compared to White Light Imaging in Endoscopic Diagnosis of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
    Jae Gon Lee, In Kyung Yoo, Abdullah Ozgur Yeniova, Sang Pyo Lee
    Gut and Liver.2024; 18(3): 444.     CrossRef
  • Linked Color Imaging for Stomach
    Eiji Umegaki, Hiraku Misawa, Osamu Handa, Hiroshi Matsumoto, Akiko Shiotani
    Diagnostics.2023; 13(3): 467.     CrossRef
  • Role of linked color imaging for upper gastrointestinal disease: present and future
    Sang Pyo Lee
    Clinical Endoscopy.2023; 56(5): 546.     CrossRef
  • Appropriate Color Enhancement Settings for Blue Laser Imaging Facilitates the Diagnosis of Early Gastric Cancer with High Color Contrast
    Yuji Hiraoka, Yoshimasa Miura, Hiroyuki Osawa, Yoshie Nomoto, Haruo Takahashi, Masato Tsunoda, Manabu Nagayama, Takashi Ueno, Alan Kawarai Lefor, Hironori Yamamoto
    Journal of Gastric Cancer.2021; 21(2): 142.     CrossRef
  • 3,742 View
  • 118 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
A “One Accessory and One Guidewire-in-One Channel” Technique in a Patient with Billroth II Anastomosis
Kook Hyun Kim, Sung Bum Kim, Tae Nyeun Kim
Clin Endosc 2021;54(1):139-140.   Published online July 7, 2020
DOI: https://doi.org/10.5946/ce.2020.087
PDFSupplementary MaterialPubReaderePub
  • 3,682 View
  • 95 Download
Close layer
Boost Your Learning with Quiz
Differential Diagnosis for Chronic Diarrhea: Are Multiple Random Biopsies with Colonoscopy Mandatory?
Shin Hee Lee, Sang-Bum Kang
Clin Endosc 2021;54(1):141-142.   Published online January 20, 2021
DOI: https://doi.org/10.5946/ce.2021.030
PDFPubReaderePub
  • 5,071 View
  • 143 Download
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP